Denmark vs Georgia: Protecting minority investors: Ease of shareholder suits index (0-10)
Denmark
70
in 2013
Georgia
70
in 2013
Denmark rank
44th
Georgia rank
44th
Protecting minority investors: Ease of shareholder suits index (0-10) over time
- Denmark
- Georgia
How they compare
Denmark currently reports 70 against 70 in Georgia, a difference of 0.
The two have swapped places 1 time across 9 shared years of data; in 2005 it was Denmark ahead.
Denmark ranks 44th and Georgia ranks 44th of 191 countries.
Denmark has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Denmark | Georgia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 70 | 50 | 20 | Denmark |
| 2010s | 70 | 70 | 0 | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher protecting minority investors: ease of shareholder suits index (0-10), Denmark or Georgia?
- Denmark, at 70 against 70 in Georgia as of 2013.
- What is the difference in protecting minority investors: ease of shareholder suits index (0-10) between Denmark and Georgia?
- 0, with Denmark ahead.
- How many years of comparable data are there for Denmark and Georgia?
- 9 years are reported by both, from 2005 to 2013.
- How do Denmark and Georgia rank globally for protecting minority investors: ease of shareholder suits index (0-10)?
- Denmark ranks 44th and Georgia ranks 44th of 191 countries.
- Where does this data come from?
- The World Bank, published as Protecting minority investors: Ease of shareholder suits index (0-10) (DB06-14 methodology) - Score. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The score for ease of shareholder suits index benchmarks economies with respect to the regulatory best practice on the indicator. The score is indicated on a scale from 0 to 100, where 0 represents the worst regulatory performance and 100 the best regulatory performance, and is computed based on the methodology in the DB06-14 studies.